Published in Ann Surg on January 01, 2002
Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach. J Gastric Cancer (2014) 1.31
Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections. Langenbecks Arch Surg (2012) 1.28
Follow-up of gastric cancer: a review. Gastric Cancer (2006) 1.10
Radiofrequency ablation for treating liver metastases from a non-colorectal origin. Korean J Radiol (2011) 1.09
Strategies for treating liver metastasis from gastric cancer. Surg Today (2010) 1.02
Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer. Langenbecks Arch Surg (2008) 1.02
Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile? HPB (Oxford) (2012) 1.01
Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines. Gastric Cancer (2014) 1.01
Liver resections in metastatic gastric cancer. HPB (Oxford) (2010) 1.00
The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review. Langenbecks Arch Surg (2014) 1.00
Prognostic factors for survival in patients with hepatic recurrence after curative resection of gastric cancer. World J Surg (2009) 1.00
Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer. Hepatol Int (2010) 0.99
Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review. BMC Gastroenterol (2011) 0.98
Outcome of operative therapy of hepatic metastatic stomach carcinoma: a retrospective analysis. World J Surg (2012) 0.97
Hepatic resection for the treatment of liver metastases in gastric carcinoma: review of the literature. HPB (Oxford) (2006) 0.96
The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone. Trials (2009) 0.91
Surgical treatment of recurrent gastric cancer. Gastric Cancer (2008) 0.89
Chemotherapy and resection for gastric cancer with synchronous liver metastases. World J Gastroenterol (2013) 0.89
Resection of liver metastases is beneficial in patients with gastric cancer: report on 15 cases and review of literature. Gastric Cancer (2011) 0.89
Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases. BMC Surg (2012) 0.87
Positron emission tomography/computer tomography: challenge to conventional imaging modalities in evaluating primary and metastatic liver malignancies. World J Gastroenterol (2007) 0.86
Surgical resection of hepatic metastases from gastric cancer: outcomes from national series in England. Gastric Cancer (2016) 0.86
Surgical treatment of liver metastases of gastric cancer: state of the art. World J Surg Oncol (2012) 0.85
Radiofrequency ablation for hepatic metastasis from gastric adenocarcinoma. Yonsei Med J (2008) 0.85
Repeat hepatectomy for recurrent liver metastasis from gastric carcinoma. World J Surg (2013) 0.85
Pancreaticoduodenectomy for advanced gastric cancer with pancreaticoduodenal region involvement. World J Gastroenterol (2008) 0.84
Clinical outcome of patients with pancreatic metastases from renal cell cancer. BMC Cancer (2015) 0.84
Surgery for Liver Metastases From Gastric Cancer: A Meta-Analysis of Observational Studies. Medicine (Baltimore) (2015) 0.83
Major hepatectomy for isolated metastases from gastric adenocarcinoma. HPB (Oxford) (2003) 0.82
Hepatic resection for hepatic metastases from gastric adenocarcinoma. J Gastric Cancer (2013) 0.81
Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302). Gastric Cancer (2015) 0.81
A patient with gastric cancer and liver metastases successfully treated with combination chemotherapy including S-1. Int J Clin Oncol (2007) 0.80
Analysis of risk factors for the interval time, number and pattern of hepatic metastases from gastric cancer after radical gastrectomy. World J Gastroenterol (2008) 0.80
Liver-directed treatments for liver metastasis from gastric adenocarcinoma: comparison between liver resection and radiofrequency ablation. Gastric Cancer (2015) 0.79
Isolation and characterization of circulating tumor cells from human gastric cancer patients. J Cancer Res Clin Oncol (2014) 0.79
A case with synchronous multiple liver metastases from gastric carcinoma: postoperative long-term disease-free survival. Langenbecks Arch Surg (2008) 0.79
Long-term survival after surgical resection for liver metastasis from gastric cancer: two case reports. Cancer Res Treat (2006) 0.79
Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial. BMC Cancer (2016) 0.79
Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer. Clin Exp Metastasis (2013) 0.78
Resection of Large Metachronous Liver Metastasis with Gastric Origin: Case Report and Review of the Literature. Cureus (2016) 0.78
Treatment outcomes of hepatectomy for liver metastases of gastric cancer diagnosed using contrast-enhanced magnetic resonance imaging. Gastric Cancer (2016) 0.77
Trimodal Therapy: Combining Hyperthermia with Repurposed Bexarotene and Ultrasound for Treating Liver Cancer. ACS Nano (2015) 0.77
Percutaneous right portal vein embolization with polyvinyl alcohol particles in gastric cancer metastasis: report of a case. Surg Today (2005) 0.76
High survival in patients operated for small isolated liver metastases from gastric cancer: a multi-institutional study. World J Surg (2014) 0.76
Surgical resection of gastric cancer hepatic metastases: expanding the indications for curative treatment. Transl Gastroenterol Hepatol (2016) 0.75
Capecitabine plus Cisplatin treatment for advanced gastric cancer in a patient with hepatic impairment secondary to metastases. Gastrointest Cancer Res (2012) 0.75
Hepatectomy for liver metastases from gastric cancer: a systematic review. BMC Surg (2017) 0.75
Long-term survival with complete remission after hepatic arterial infusion chemotherapy for liver metastasis from gastric cancer: a case report. World J Surg Oncol (2015) 0.75
Modern imaging techniques for preoperative detection of distant metastases in gastric cancer. World J Gastroenterol (2015) 0.75
Palliative gastrectomy is beneficial in selected cases of metastatic gastric cancer. BMC Palliat Care (2017) 0.75
Comparison of Therapeutic Efficacy between Gastrectomy with Transarterial Chemoembolization Plus Systemic Chemotherapy and Systemic Chemotherapy Alone in Gastric Cancer with Synchronous Liver Metastasis. Chin Med J (Engl) (2015) 0.75
Clinical modalities for management of gastric cancer hepatic metastasis. Int J Clin Exp Med (2015) 0.75
Hepatectomy Offers Superior Survival Compared with Non-surgical Treatment for ≤3 Metastatic Tumors with Diameters <3 cm from Gastric Cancer: A Retrospective Study. World J Surg (2015) 0.75
Evaluation of hepatectomy and palliative local treatments for gastric cancer patients with liver metastases: a propensity score matching analysis. Oncotarget (2017) 0.75
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Resection of colorectal liver metastases. World J Surg (1995) 7.73
Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg (1990) 4.36
Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery (1988) 3.47
Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol (1997) 3.09
Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg (2000) 2.92
Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg (1992) 2.10
Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer. J Clin Oncol (1999) 1.84
Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg (1995) 1.81
Macroscopic intrabiliary growth of liver metastases from colorectal cancer. Surgery (1999) 1.49
Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum (1999) 1.46
Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg (1994) 1.32
Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg (1999) 1.31
Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol (1997) 1.24
A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer. Ann Surg (1997) 1.22
Evaluation of treatment for gastric cancer with liver metastasis. Cancer (1985) 1.12
Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma. Clinicopathologic study of 152 first resection cases. Cancer (2000) 1.11
Synchronous, metachronous, and multiple hepatic resections of liver tumors originating from primary gastric tumors. Surgery (1993) 1.10
Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery (1991) 1.02
Resection of liver metastases of colorectal carcinoma. World J Surg (1997) 0.93
Resection versus resection combined with adjuvant pre- and post-operative chemotherapy--immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. Hepatogastroenterology (1995) 0.93
Effect of intra-hepatoarterial infusion of MMC and CDDP for gastric cancer patients with liver metastases. Surg Today (1992) 0.91
Clinical evaluation of hepatic arterial infusion of low dose-CDDP and 5-FU with hyperthermotherapy: a preliminary study for liver metastases from esophageal and gastric cancer. Hepatogastroenterology (1999) 0.85
[Preventive chemotherapy for residual liver after resection of hepatic metastasis from colorectal cancer]. Gan To Kagaku Ryoho (1995) 0.81
Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension (2005) 2.67
Comparison of central blood pressure and cardio-ankle vascular index for association with cardiac function in treated hypertensive patients. Hypertens Res (2009) 2.07
Left ventricular diastolic dysfunction as assessed by echocardiography in metabolic syndrome. Hypertens Res (2006) 1.82
Cytomegalovirus-associated acute gastric mucosal lesion in an immunocompetent host. Intern Med (2009) 1.54
Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase. Cardiovasc Res (2002) 1.51
Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma. Hepatology (2004) 1.48
Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer. Ann Surg (2013) 1.39
Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Int J Oncol (2008) 1.33
Dual-time-point 18F-FDG PET for the evaluation of gallbladder carcinoma. J Nucl Med (2006) 1.17
Local expression of tumor necrosis factor-alpha and interleukin-10 on wound healing of intestinal anastomosis during endotoxemia in mice. J Surg Res (2002) 1.02
Application of preoperative portal vein embolization before major hepatic resection in patients with normal or abnormal liver parenchyma. Surgery (2002) 1.00
Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice. Cancer Res (2003) 0.99
Evaluation of delayed additional FDG PET imaging in patients with pancreatic tumour. Nucl Med Commun (2005) 0.97
Improved microcirculatory effect of D-allose on hepatic ischemia reperfusion following partial hepatectomy in cirrhotic rat liver. J Biosci Bioeng (2006) 0.97
Lymphocytic infiltration surrounding liver metastases from colorectal cancer. J Surg Oncol (2003) 0.97
Preoperative assessment of the aberrant bile duct using multislice computed tomography cholangiography. Am J Surg (2005) 0.96
D-Allose has a strong suppressive effect against ischemia/reperfusion injury: a comparative study with allopurinol and superoxide dismutase. J Hepatobiliary Pancreat Surg (2004) 0.95
Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and omega-3 fatty acids supplemented immunonutrition. World J Surg (2009) 0.94
Evaluation of liver function for hepatic resection for hepatocellular carcinoma in the liver with damaged parenchyma. J Surg Res (2004) 0.94
99mTc-GSA liver dynamic SPECT for the preoperative assessment of hepatectomy. Ann Nucl Med (2003) 0.93
Extraperitoneal colostomy in laparoscopic abdominoperineal resection using a laparoscopic retractor. Surg Today (2012) 0.93
Cyclin B1, unlike cyclin G1, increases significantly during colorectal carcinogenesis and during later metastasis to lymph nodes. Int J Oncol (2003) 0.93
Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver. Int J Oncol (2005) 0.93
Evaluation of the effect of age on functioning hepatocyte mass and liver blood flow using liver scintigraphy in preoperative estimations for surgical patients: comparison with CT volumetry. J Surg Res (2002) 0.93
Ischemic preconditioning of the murine liver protects through the Akt kinase pathway. Hepatology (2006) 0.93
Seasonal blood pressure variation and its relationship to environmental temperature in healthy elderly Japanese studied by home measurements. Clin Exp Hypertens (2010) 0.91
Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases. Ann Surg Oncol (2012) 0.91
Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas. Ann Surg Oncol (2008) 0.89
Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions. J Surg Oncol (2003) 0.89
Prognostic value of thermographical findings in patients with primary breast cancer. Breast Cancer Res Treat (2002) 0.88
Visit-to-visit variability in blood pressure over a 1-year period is a marker of left ventricular diastolic dysfunction in treated hypertensive patients. Hypertens Res (2011) 0.88
Outer arm fucosylation of N-glycans increases in sera of hepatocellular carcinoma patients. Biochem Biophys Res Commun (2008) 0.88
Isolated splenic metastasis of ovarian cancer 20 years after operation: a case report and literature review. Tumori (2011) 0.87
Hand-assisted laparoscopic splenectomy for thrombocytopenia in patients with cirrhosis. Surg Today (2012) 0.87
Independent determinants of the Tei index in hypertensive patients with preserved left ventricular systolic function. Int Heart J (2009) 0.87
Left ventricular diastolic dysfunction in normotensive diabetic patients in various age strata. Diabetes Res Clin Pract (2007) 0.87
Comparison of early and delayed FDG PET for evaluation of biliary stricture. Nucl Med Commun (2007) 0.86
Loss of p57KIP2 is associated with colorectal carcinogenesis. Int J Oncol (2003) 0.86
Safety analysis of two different regimens of uracil-tegafur plus leucovorin as adjuvant chemotherapy for high-risk stage II and III colon cancer in a phase III trial comparing 6 with 18 months of treatment: JFMC33-0502 trial. Cancer Chemother Pharmacol (2014) 0.86
Neutrophil elastase inhibitor (sivelestat) preserves antitumor immunity and reduces the inflammatory mediators associated with major surgery. Surg Today (2007) 0.86
A patient with unresectable advanced pancreatic cancer achieving long-term survival with gemcitabine chemotherapy. World J Gastroenterol (2008) 0.86
18F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer. World J Gastroenterol (2011) 0.85
Analysis of heart rate variability as an index of noncardiac surgical stress. Heart Vessels (2008) 0.84
Analysis of Bordetella pertussis agglutinin titers during an outbreak of pertussis at a university in Japan. Jpn J Infect Dis (2010) 0.84
Association between urinary 8-hydroxydeoxyguanosine, an indicator of oxidative stress, and the cardio-ankle vascular index in hypertensive patients. J Atheroscler Thromb (2012) 0.84
Echocardiographic assessment of the cardio-renal connection: is left ventricular hypertrophy or diastolic function more closely correlated with estimated glomerular filtration rate in patients with cardiovascular risk factors? Clin Exp Hypertens (2010) 0.82
Colo-colic intussusception associated with Henoch-Schönlein purpura in adults. J Gastroenterol Hepatol (2007) 0.82
Amelioration of myocardial global ischemia/reperfusion injury with volume-regulatory chloride channel inhibitors in vivo. Transplantation (2002) 0.81
Cardiac function as assessed by echocardiography in the oldest old > or = 90 years of age. Int Heart J (2007) 0.81
Selenium deficiency is associated with insulin resistance in patients with hepatitis C virus-related chronic liver disease. Nutr Res (2011) 0.81
Heart rate variability for evaluating surgical stress and development of postoperative complications. Clin Exp Hypertens (2008) 0.81
Association between left ventricular hypertrophy and changes in arterial stiffness during hypertensive treatment. Clin Exp Hypertens (2013) 0.80
Predictors of postoperative complications in elderly and oldest old patients with gastric cancer. Gastric Cancer (2014) 0.79
Correlation of arterial stiffness to left ventricular function in patients with reduced ejection fraction. Tohoku J Exp Med (2011) 0.79
Malposition of femoral venous cannulation. Am J Surg (2005) 0.79
Detection of increased arterial stiffness in a patient with early stage of large vessel vasculitis by measuring cardio-ankle vascular index. Tohoku J Exp Med (2009) 0.79
Seasonal variation in estimated glomerular filtration rate based on serum creatinine levels in hypertensive patients. Tohoku J Exp Med (2011) 0.79
Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver disease. Diabetol Metab Syndr (2013) 0.79
Association between arterial stiffness and pulmonary function in hypertensive patients. Hypertens Res (2011) 0.79
Protective effects of D-allose against ischemia reperfusion injury of the rat liver. J Hepatobiliary Pancreat Surg (2003) 0.79
Age-related decrease in inferior vena cava diameter measured with echocardiography. Tohoku J Exp Med (2010) 0.79